The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia

Background: Multiple sclerosis (MS) misdiagnosis may cause physical and emotional damage to patients. Objectives: The objective of this study is to determine the frequency and characteristics of MS misdiagnosis in patients referred to the Multiple Sclerosis Centre of Catalonia. Methods: We designed a prospective study including all new consecutive patients referred to our centre between July 2017 and June 2018. Instances of misdiagnosis were identified, and referral diagnosis and final diagnosis were compared after 1 year of follow-up. Association of misdiagnosis with magnetic resonance imaging (MRI) findings, presence of comorbidities and family history of autoimmunity were assessed. Results: A total of 354 patients were referred to our centre within the study period, 112 (31.8%) with ‘established MS’. Misdiagnosis was identified in eight out of 112 cases (7.1%). MRI identified multifocal white matter lesions, deemed non-specific or not suggestive of MS in all misdiagnosed cases. Patients with MS misdiagnosis had more comorbidities in general than patients with MS (p = 0.026) as well as a personal history of autoimmunity (p < 0.001). Conclusion: A low frequency of MS misdiagnosis was found in our clinical setting. Multifocal non-specific white matter lesions in referral MRI examinations and the presence of comorbidities, including a personal history of autoimmunity, seem to be contributing factors to misdiagnosis.

[1]  P. Morgan,et al.  Single Test to ARrive at Multiple Sclerosis (STAR-MS) diagnosis: A prospective pilot study assessing the accuracy of the central vein sign in predicting multiple sclerosis in cases of diagnostic uncertainty , 2020, Multiple sclerosis.

[2]  F. Yamashita,et al.  Cerebral White Matter Hyperintensity as a Healthcare Quotient , 2019, Journal of clinical medicine.

[3]  R. Meuli,et al.  The “central vein sign” in patients with diagnostic “red flags” for multiple sclerosis: A prospective multicenter 3T study , 2019, Multiple sclerosis.

[4]  O. Ciccarelli,et al.  Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines , 2019, Brain : a journal of neurology.

[5]  A. Solomon.  Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis. , 2019, Continuum.

[6]  J. Correale,et al.  Multiple Sclerosis Misdiagnosis: A Persistent Problem to Solve , 2019, Front. Neurol..

[7]  M. Luu,et al.  Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers. , 2019, Multiple sclerosis and related disorders.

[8]  M. Benedetti,et al.  2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? , 2019, Multiple sclerosis and related disorders.

[9]  Jaume Sastre-Garriga,et al.  Treatment of multiple sclerosis — success from bench to bedside , 2018, Nature Reviews Neurology.

[10]  A. Siva.  Common Clinical and Imaging Conditions Misdiagnosed as Multiple Sclerosis: A Current Approach to the Differential Diagnosis of Multiple Sclerosis. , 2018, Neurologic clinics.

[11]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[12]  H. Tamim,et al.  Alternative diagnoses in patients referred to specialized centers for suspected MS. , 2017, Multiple sclerosis and related disorders.

[13]  A. Solomon,et al.  The tension between early diagnosis and misdiagnosis of multiple sclerosis , 2017, Nature Reviews Neurology.

[14]  David H. Miller,et al.  Diagnosis of multiple sclerosis: progress and challenges , 2017, The Lancet.

[15]  B. Weinshenker,et al.  A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis , 2015, Current Neurology and Neuroscience Reports.

[16]  Andrew J Solomon,et al.  Misdiagnosis of Multiple Sclerosis: Frequency, Causes, Effects, and Prevention , 2013, Current Neurology and Neuroscience Reports.

[17]  Liam Smeeth,et al.  Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? , 2009, American journal of epidemiology.

[18]  Jeffrey A. Cohen,et al.  Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.

[19]  David H. Miller,et al.  MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation” , 2006, The Lancet Neurology.

[20]  D. Mattson.  Update on the diagnosis of multiple sclerosis , 2002, Expert review of neurotherapeutics.

[21]  W. Heiss,et al.  New diagnostic criteria for multiple sclerosis , 2002, Annals of neurology.

[22]  B. Weinshenker,et al.  Epidemiology of multiple sclerosis. , 1996, Neurologic clinics.

[23]  M. Mumenthaler.  [Multiple sclerosis, diagnosis and differential diagnosis]. , 1967, Praxis.

[24]  T. Fog,et al.  [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.

[25]  A. Sempere,et al.  [Epidemiology of multiple sclerosis in Spain]. , 2019, Revista de neurologia.

[26]  Ludwig Kappos,et al.  The current role of MRI in differentiating multiple sclerosis from its imaging mimics , 2018, Nature Reviews Neurology.

[27]  M. Filippo,et al.  “Better explanations” in multiple sclerosis diagnostic workup , 2019, Neurology.